Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer
Biliary tract cancers (BTCs), for their low incidence, have been often considered together. Gallbladder cancer (GBC) is the most common biliary tract malignancy, characterized by late diagnosis and poor prognosis, and although it is considered a rare tumor in western countries, other areas of the wo...
Guardado en:
Autores principales: | Matteo Canale, Manlio Monti, Ilario Giovanni Rapposelli, Paola Ulivi, Francesco Giulio Sullo, Giulia Bartolini, Elisa Tiberi, Giovanni Luca Frassineti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/16b026a0d3554b54ae9b39c9fb66b95d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
KIF15 knockdown suppresses gallbladder cancer development
por: Jun Wang, et al.
Publicado: (2021) -
Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications
por: Hendrien Kuipers, et al.
Publicado: (2021) -
Outcome of routine histopathological examination of gallbladder specimen following elective laparoscopic cholecystectomy
por: Ashesh Kumar Jha, et al.
Publicado: (2021) -
Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
por: Paola Ulivi, et al.
Publicado: (2021) -
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor
por: García,Patricia, et al.
Publicado: (2020)